Morepen Laboratories Ltd Sees Exceptional Volume Surge Amid Strong Price Momentum

Robust Trading Activity and Volume Analysis

On 18 Aug 2026, Morepen Laboratories Ltd (symbol: MOREPENLAB) emerged as one of the most actively traded equities by volume on the Indian stock exchanges. The total traded volume reached an impressive 1.28 crore shares, translating to a traded value of approximately ₹117.1 crores. This volume figure significantly exceeds the stock’s recent averages, reflecting a pronounced spike in market participation.

The stock opened at ₹89.82 and touched a day high of ₹92.50 before settling at ₹91.70 as of the last update at 09:43:46 IST. Notably, the stock hit a new 52-week high of ₹91.22 during the session, underscoring the strength of the current rally. Despite a minor day-on-day percentage change of -0.96%, the stock outperformed its sector benchmark by 1.23% and delivered a 2.04% return on the day, compared to the Pharmaceuticals & Biotechnology sector’s 0.30% gain and the Sensex’s decline of 0.21%.

Price Momentum and Moving Averages

Morepen Laboratories has demonstrated consistent upward momentum, registering gains for four consecutive trading sessions. Over this period, the stock has delivered a robust 24.01% return, signalling strong investor confidence. The price currently trades above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — which is a classic technical indicator of a bullish trend. This alignment of moving averages suggests sustained buying interest and a positive medium to long-term outlook.

Rising Investor Participation and Delivery Volumes

Investor participation has notably increased, with delivery volumes on 17 Aug 2026 reaching 1.27 crore shares. This figure represents a 77.31% rise compared to the five-day average delivery volume, indicating strong accumulation by investors rather than speculative intraday trading. Such a surge in delivery volumes often points to genuine interest from institutional and retail investors alike, reinforcing the stock’s upward trajectory.

Liquidity and Market Capitalisation Context

With a market capitalisation of ₹5,022 crores, Morepen Laboratories is classified as a small-cap stock within the Pharmaceuticals & Biotechnology industry. Despite its relatively modest size, the stock exhibits sufficient liquidity, with the capacity to handle trade sizes up to ₹5.56 crores based on 2% of the five-day average traded value. This liquidity profile supports active trading without excessive price impact, making it attractive for both short-term traders and longer-term investors.

Mojo Score Upgrade and Rating Implications

MarketsMOJO’s proprietary scoring system has recently upgraded Morepen Laboratories Ltd’s Mojo Grade from Sell to Hold as of 03 Aug 2026, reflecting an improved outlook based on fundamental and technical parameters. The current Mojo Score stands at 64.0, signalling a neutral to moderately positive stance. This upgrade suggests that while the stock is not yet a strong buy, it has moved out of the sell territory, supported by improving financial metrics and market sentiment.

Accumulation/Distribution Signals and Technical Outlook

The combination of rising delivery volumes, sustained price gains, and trading above key moving averages points to a clear accumulation phase. Investors appear to be steadily building positions, which is often a precursor to further price appreciation. The stock’s ability to outperform its sector and broader market indices despite a slight day-on-day dip indicates resilience and underlying strength.

Technical analysts will note the significance of the new 52-week high, which often acts as a psychological barrier. Breaking this level can trigger additional buying interest from momentum traders and institutional investors. The current trading range between ₹88.83 (day low) and ₹92.50 (day high) suggests a healthy volatility band, providing opportunities for active traders while maintaining an overall upward bias.

Sector and Market Context

The Pharmaceuticals & Biotechnology sector has shown moderate gains recently, with a 1-day return of 0.30%, while the broader Sensex index declined by 0.21%. Morepen Laboratories’ outperformance within this context highlights its relative strength and potential as a sectoral leader among small-cap stocks. Investors seeking exposure to the pharmaceutical space may find Morepen’s current momentum and improving fundamentals compelling.

Investor Takeaway and Outlook

Morepen Laboratories Ltd’s recent trading activity underscores a phase of strong accumulation and positive price momentum. The stock’s ability to sustain gains above multiple moving averages, coupled with a significant rise in delivery volumes, suggests that investors are increasingly confident in its prospects. While the Mojo Grade remains at Hold, the upgrade from Sell and the current technical setup indicate improving fundamentals and market sentiment.

Investors should monitor the stock’s ability to maintain its new 52-week high and watch for any shifts in volume patterns that could signal distribution phases. Given the stock’s small-cap status, volatility may remain elevated, but the current trend favours accumulation. Those seeking exposure to the Pharmaceuticals & Biotechnology sector may consider Morepen Laboratories as a candidate for portfolio inclusion, balancing its growth potential against inherent risks.

Overall, the combination of exceptional volume, rising investor participation, and technical strength positions Morepen Laboratories Ltd as a noteworthy stock to watch in the current market environment.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today